REVENUE INTERESTS PURCHASE AGREEMENT Dated as of October 5, 2012 between AxoGen, Inc. and PDL BioPharma, Inc.Revenue Interests Purchase Agreement • July 30th, 2013 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • New York
This REVENUE INTERESTS PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of October 5, 2012, by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“Purchaser”).
GUARANTEE AND COLLATERAL AGREEMENT DATED AS OF OCTOBER 5, 2012 BY AXOGEN, INC., AND AXOGEN CORPORATION, AS GRANTORS IN FAVOR OF PDL BIOPHARMA, INC., AS PURCHASERGuarantee and Collateral Agreement • July 30th, 2013 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • New York
GUARANTEE AND COLLATERAL AGREEMENT, dated as of October 5, 2012 by AXOGEN, INC., a Minnesota corporation ( the “Seller”; and together with any other entity on the signature pages hereto or that may become a party hereto as a grantor as provided herein, each a “Grantor” and collectively, jointly and severally, the “Grantors”), in favor of PDL BIOPHARMA, INC., a Delaware corporation, as Purchaser (in such capacity, the “Purchaser”) under the Revenue Interests Purchase Agreement, dated as of October 5, 2012 (as amended, supplemented or otherwise modified from time to time, the “Purchase Agreement”) between the Seller and the Purchaser.
July 26, 2013AxoGen, Inc. • July 30th, 2013 • Electromedical & electrotherapeutic apparatus • New York
Reference hereby is made to that certain Revenue Interests Purchase Agreement (the “Revenue Purchase Agreement”), dated as of October 5, 2012 by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“PDL”). Capitalized terms used herein but not otherwise defined herein shall have the meanings set forth in the Revenue Purchase Agreement.
